History of BRCA mutation, status post lumpectomy at outside hospital in March 20, 2015 with calcifications near the medial margin, dense breasts, evaluate for residual disease and contralateral breast There is heterogeneous amount of fibroglandular tissue in both breasts.Mild parenchymal enhancement is noted bilaterally.Seroma/hematoma cavity in the left upper outer quadrant posterior depth measures 31 x 16 x 24 mm best seen on the T1-weighted sequence. Area of thick irregular enhancement (measuring 7 mm in thickness) is seen along the anterolateral margin of the seroma cavity which could represent area of fat necrosis versus residual disease.3 lobulated homogeneously enhancing similar morphology masses are identified two in the left breast and one in the right breast as follows:Left breast 1:00 position measuring 8 x 12 x 13 mm (bilobed)Left breast 7:00 position measuring 9 x 7 x 8 mmRight breast 3:00 position measuring 7 x 5 x 6 mm.No abnormal lymph nodes are identified in either axillary region.
1. Area of irregular thick enhancement along the anterolateral aspect of the seroma cavity could represent area of fat necrosis versus residual disease.2. Three similar most likely benign morphology masses in both breast as described above for which MR directed ultrasound is recommended. If the masses are not seen on ultrasound, six-month follow-up MRI is recommended.BIRADS: 0 - INCOMPLETE; Need additional imaging evaluationRECOMMENDATION: E - Additional Mammo/Ultrasound Workup Required.